Success Metrics

Clinical Success Rate
57.1%

Based on 4 completed trials

Completion Rate
57%(4/7)
Active Trials
2(15%)
Results Posted
50%(2 trials)
Terminated
3(23%)

Phase Distribution

Ph phase_3
2
15%
Ph phase_2
4
31%
Ph not_applicable
4
31%
Ph phase_1
2
15%

Phase Distribution

2

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
2(16.7%)
Phase 2Efficacy & side effects
4(33.3%)
Phase 3Large-scale testing
2(16.7%)
N/ANon-phased studies
4(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

2

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(4)
Terminated(3)
Other(4)

Detailed Status

Completed4
unknown4
Terminated3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
13
Active
2
Success Rate
57.1%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (16.7%)
Phase 24 (33.3%)
Phase 32 (16.7%)
N/A4 (33.3%)

Trials by Status

recruiting215%
terminated323%
completed431%
unknown431%

Recent Activity

2 active trials
Showing 5 of 13
recruitingnot_applicable

The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases?

NCT05378633
completedphase_1

Avelumab With Radiotherapy in Patients With Leptomeningeal Disease

NCT03719768
recruitingphase_3

FSRT Combines With Bevacizumab for Multiple Brain Metastases in Lung Adenocarcinoma

NCT07058428
completedphase_2

New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement

NCT02329080
terminatednot_applicable

Whole Brain Radiotherapy (WBRT) Versus Stereotactic Radiosurgery (SRS) for 4 Upto 10 Brain Metastases

NCT02353000
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT05378633Not Applicable

The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases?

Recruiting
NCT03719768Phase 1

Avelumab With Radiotherapy in Patients With Leptomeningeal Disease

Completed
NCT07058428Phase 3

FSRT Combines With Bevacizumab for Multiple Brain Metastases in Lung Adenocarcinoma

Recruiting
NCT02329080Phase 2

New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement

Completed
NCT02353000Not Applicable

Whole Brain Radiotherapy (WBRT) Versus Stereotactic Radiosurgery (SRS) for 4 Upto 10 Brain Metastases

Terminated
NCT02714010Phase 3

EGFR-TKI Concurrent With/Without WBRT in Brain Metastasis From NSCLC

Unknown
NCT03288272Phase 2

Evaluation of Repeated Whole Brain Radiotherapy Versus Best Supportive Care for Multiple Brain Metastases.

Unknown
NCT00266812Phase 2

Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED)

Terminated
NCT03002532Not Applicable

Hippocampal-sparing Whole Brain Radiotherapy for Brain Metastases From Breast Cancer

Unknown
NCT02913534

Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain Radiotherapy

Completed
NCT01363557Not Applicable

Assess the Efficacy of Whole Brain Radiation Therapy in Lung Cancer Patients With Brain Metastasis

Terminated
NCT01516983Phase 1

Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation

Completed
NCT00876759Phase 2

Whole-Brain Radiotherapy (WBRT) Versus WBRT and Integrated Boost Using Helical Tomotherapy for Multiple Brain Metastases

Unknown

All 13 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
13